Introducing the T7 Promoter Calculator, our newest model that predicts the T7 transcription rate for every start site across a genetic system's sequence, including both canonical & low-affinity sites; and redesigns T7 expression systems to remove production of long RNA byproducts
@JustinGallivan@dwidmaier It took me ~2 weeks to carry out a serious design project when it would have taken me months previously. Reducing the many low-level coding steps enabled me to think & test at the high-level. Not done yet, but I could easily see how reducing such friction accelerates research.
So proud of our inaugural @CalPolyCSM iGEM team for winning Best Measurement AND Gold 🥇 at @iGEM 2026!! Thanks to @schmidtsciences for the support and our sponsors 🙏
@ATinyGreenCell Experiencing a catastrophic single point of failure? Plz select an option:
1. a software bug brought the entire system down
2. a broken hardware device brought the entire system down
3. the only person who knew how to fix it was fired ... and now the entire system is down
Work led by Harry Adamson (now at Merck) with help from James McLellan (now at NIST) & Khushank Singhal (now at LLNL)!
Code available on GitHub [https://t.co/wnwBxolEcR] with interactive interface at https://t.co/95TvU8llnE.
Don't forget to cite!
/fin
Do you need to build & test 100s to 1000s of protein expression plasmids? Introducing a new design-build-test pipeline that increases throughput & lowers costs by ~24-fold! Stress tested on complex proteins!
https://t.co/sE9KmhZxYW
We streamline & accelerate steps combining:
/1
It’s getting popular to build autonomous labs to scale up biological data generation 24/7, but focusing automation on well-established in vitro assays with existing hardware risks solving the easiest least painful step, rather than the problems that matter the most for drug discovery.
One analogy is like generating decades of closed-course driving data with hopes of training self-driving cars that can navigate Manhattan.
I think the most valuable data from autonomous labs will come at the intersection of novel assay technologies with valuable samples - often complex animal models, organoids, primary tissue, not immortalized cancer cell lines. Not that more complexity in the assay/model system is always better, but scaling existing assays 1000x won’t overcome the fundamental limits of what they can measure. Training AI models to find drugs that existing approaches have failed to discover will probably require generating types of data that existing technologies cannot generate.
Teams building the next generation of autonomous labs need to have the skillsets to (i) invent new & uniquely valuable assay technologies & (ii) invent the custom hardware to automate them.
@KevinKaichuang@sesameandrea@KotaroTsuboyama This is a very nice paper, but (as the authors discuss) the model learns protein solubility & monomeric yield, focusing on how protein structure alters solvent interactions. I would not describe this as predicting expression.
@arjunrajlab@wc_ratcliff@grnfluoresceblg Encoding many cell types requires more genomic DNA, but prokaryotes perhaps have limited genome sizes vs. eukaryotes (yes?)
@wc_ratcliff@arjunrajlab@grnfluoresceblg In an alternate timeline, we could have had multi-cellular bacterial tissues & organisms. "Developmental pathways" causing cytoplasm to specialize (like a peroxisome, endosome, etc) with greater metabolite sharing across bacterial cells, e.g. using ~Type IV secretion needles.
@jboysen0@anselmlevskaya@curiouswavefn 1000000x more people have been killed by bullets vs bioweapons
Why don’t you EA your way towards more effective gun laws in the US, which would have way more effectiveness towards preventing mass murders?
Also, really easy to make mustard gas. Chem is worse than bio. See WWI.
I'm excited about this new class of generative models that allow us to understand how DNA sequence mediates regulation of transcription factor and nucleosome assemblies at single molecule resolution. 1/
@WillPVGreen When Addgene was first created, they would stock strains, but I think it became too expensive.
ATCC has the expertise to do this, not sure if it's sustainable. Perhaps for a subset of culturable organisms that can be frozen ok.
@BalbontinLab@NikoMcCarty Yep, one antibiotic for selection of one plasmid induces some stress.
Two antibiotics for dual plasmid selection adds a lot more stress.
Excess stress can alter measurements & outcomes.